Page 7 - Upl

Top trading ideas by CapitalVia Global Research: Buy UPL, Equitas Holdings

Technical Calls by Gaurav Garg, Head of Research at CapitalVia Global Research Limited- Investment Advisor

Stock recommendations by Tradebulls Securities: Buy NIIT Tech, sell UPL

Nifty outlook and two stock calls by Sacchitanand Uttekar, DVP - Technical (Equity) of Tradebulls Securities

Technical calls by Religare Broking: Buy Dabur, HDFC, Hero Motocorp

Weekly Technical Recommendations by Religare Broking Ltd.

UPL ordered to pay $31 mn to US-based AgroFresh in patent infringement case

UPL said in a statement it's disappointed in the verdict and will appeal

Today's picks: From UPL to Coal India, hot stocks to watch on Tuesday

For Coal India, keep a stop at 192 and go short.

Latin America performance steadies the ship for UPL, say analysts

India, European biz underperformed, but the firm has maintained its FY20 revenue guidance

Lower China demand, higher US exports to Europe likely to hurt UPL

Despite trade tensions between the US and China, soybean premiums have not widened

UPL faces near-term growth headwinds over European concerns, Arysta buy

After a 24 per cent run-up on the bourses from its October low, the stock of UPL fell about three per cent on Tuesday. Fresh concern on European growth (due to grought there) has the Street worried at the agrochemicals and industrial chemicals entityEuropean sales have been sluggish for most of this year and after completion of the acquisition of Arysta, its dependence on Europe is expected to increase. The region contributed about 24 per cent to UPL's sales in 2017-18.Analysts see an impact on demand for fungicide in Europe, given lower rainfall and higher temperatures, leading to fewer attacks of fungus. They also see some pricing pressure for UPL's products. Analysts at CIMB say the company faces volume and pricing risk for Mancozeb, a fungicide. Over the past few years, significant incremental revenue in UPL's agrochemical division was derived from Mancozeb. The molecule is now up against new formulations from Bayer and DowDuPont, which are under patent periods. Hence, UPL could .

UPL surges 15% after Arysta deal; analysts see more upside for the stock

The stock surged 15% to Rs 631 after the company announced the acquisition of Arysta LifeScience - the agrochemical business of US-based Platform Chemicals - for a consideration of US $ 4.2 billion.

UPL's $4.2 bn purchase of ArystaLifeScience to deepen its global footprint

TPG joins hand with Abu Dhabi Investment Authority to back the transaction, JP Morgan is deal adviser

UPL's turnaround script for FY19: It hasn't been the best of starts, indeed

After last year's miss, it has guided for robust show in current year on improvement in global prices, better margins and strong India show

Q2 miss an opportunity to stock up UPL

Adjusting for lower revenue growth due to currency headwinds, analysts' earnings estimates, target prices still show upside

UPL: Steady outlook after transient hiccups

Analysts see earnings growth driving stock price higher, but any big buy may stretch balance sheet

India cheer for UPL as scrip at all-time high on BSE, LatAm worries remain

The UPL stock hit an all-time high of ~892 on the BSE on Tuesday, on expectations that a normal monsoon will improve its volumes and boost revenue growth. India accounts for 20 per cent of its consolidated revenues. Analysts at Emkay Research said a favourable monsoon should see a buoyant demand for agrochemicals in the coming Kharif season. Also, a shift in crop pattern towards cotton, rice and maize will benefit the sector. The management expects the growth to continue in FY18, with revenues growing at 12-15 per cent and margins expanding 50-75 basis points (bps), on the back of a strong global agrochemical demand favouring generic players such as UPL. Revenue in FY17 was up 16 per cent, while margins expanded 110 bps year-on-year. Over the past four years, the company has been able to outperform the global agrochemical sector, given the shift to generic products as farmers sought to cut their costs due to a sharp decline in global crop prices. Over the FY17-20 period, analysts at ..

UPL net profit jumps over three-fold at Rs 741.59 cr in Q4

Total income went up to Rs 17,123.44 crore in the 2016-17 fiscal

Analysts upbeat on UPL stock

Sales growth in Brazil and India, as well as margin gains from developed markets, should result in strong earnings over FY17-19